Lemaitre Vascular LMAT
NASDAQ LMAT
$78.74 -0.73 (-0.92%)
As of: Sep 10, 2026 · 3:59 PM EDT

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026)

Lemaitre Vascular's (LMAT) quarterly Total Non-Current Liabilities came in at $218.7 million in Q2 2026, up 2.23% year-over-year from $214.0 million in Q2 2025, and down 1.28% quarter-over-quarter from $221.6 million in Q1 2026.

Analysis

Lemaitre Vascular (LMAT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Lemaitre Vascular (LMAT) has reported Total Non-Current Liabilities for 17 consecutive years, with $218.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 2.23% year-over-year to $218.7 million in Q2 2026; TTM through Jun 2026 was $218.7 million, a 2.23% increase from a year earlier, with the FY2025 full-year figure at $220.7 million, up 3.28% from the prior year.
  • Total Non-Current Liabilities was $218.7 million for Q2 2026 at Lemaitre Vascular, down from $221.6 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $221.6 million in Q1 2026 and troughed at $32.0 million in Q1 2022.
  • A 5-year average of $109.0 million and a median of $44.2 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities sank 50.91% in 2022 and jumped 417.24% in 2025, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $40.1 million in 2022, then increased by 16.21% to $46.6 million in 2023, then soared by 358.48% to $213.7 million in 2024, then gained by 3.28% to $220.7 million in 2025, then retreated by 0.89% to $218.7 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $218.7 million (Q2 2026), $221.6 million (Q1 2026), and $220.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn -
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 1.92 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 40.46 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 2.57 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 3.68 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 3.44 Bn
10 Lemaitre Vascular 1.80 Bn 1.43 Bn 50.76 Mn 218.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 218.75 Mn
Mar 31, 2026 221.59 Mn
Dec 31, 2025 220.71 Mn
Sep 30, 2025 218.21 Mn
Jun 30, 2025 213.97 Mn
Mar 31, 2025 207.56 Mn
Dec 31, 2024 213.70 Mn
Sep 30, 2024 45.06 Mn
Jun 30, 2024 41.37 Mn
Mar 31, 2024 43.28 Mn
Dec 31, 2023 46.61 Mn
Sep 30, 2023 43.23 Mn
Jun 30, 2023 40.38 Mn
Mar 31, 2023 38.42 Mn
Dec 31, 2022 40.11 Mn
Sep 30, 2022 38.40 Mn
Jun 30, 2022 38.89 Mn
Mar 31, 2022 32.04 Mn
Dec 31, 2021 35.95 Mn
Sep 30, 2021 36.83 Mn